Lung Cancer: A Wily Genetic Opponent.
Where this comes from
- Record sourced from PubMed, PMID 28525750.
- Also identified by DOI 10.1016/j.cell.2017.05.001.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In two companion reports, the TRACERx consortium investigates tumor heterogeneity and evolution in early-stage non-small cell lung cancer. The studies highlight the prognostic value of copy-number heterogeneity assessment in tumor biopsies and circulating tumor DNA detection in plasma and suggest that tracking the evolution of lung cancers might aid clinical practice.
Medical subject headings
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms